Delivery Order SPE2DB22D3016-SPE2DB24FAQB2
Award Date
3/15/24
Potential Completion Date
3/18/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $33,787.43 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 11, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that AmerisourceBergen Drug...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,599.60 firm fixed price delivery order contract to provide ELIQUIS 5 MG TABLET 60S. This order falls under a larger, single-award, indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 5 MG TABLET 60S. This $13,208.01 order, which has a completion date of February 8, 2024, is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,065.21 firm fixed price delivery order contract (SPE2DX15D3504|SPE2DX24F05K0) for the supply of ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Firm Fixed Price delivery order contract, worth $5,620.74, to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999, which AmerisourceBergen holds with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,956.86, is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ELIQUIS 5 MG TABLET 60S. The contract, valued at $50,135.09, has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This contract is part of a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $7,807.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565767348 ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,243.74 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $6,359.10 firm fixed price delivery order contract to provide ELIQUIS 5 MG TABLET 60S. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for...